)
Visual
test
Evogene
Evogene (EVGN) investor relations material
Evogene Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary20 Nov, 2025
Executive summary
Advanced strategic transition to focus on computational chemistry and generative AI for small molecule design in pharma and agriculture, with Campus AI as the core technology engine.
Completed major organizational change and cost reduction plan, resulting in a leaner, more focused company.
Sale of Lavie Bio's activities and Microboost AI for Ag to ICL generated $7.9 million in Q3 2025, strengthening the balance sheet.
Integrated AgPlenus more deeply into core operations and scaled down Biomica and Canonic activities.
Strategic collaborations in ag-chemicals (Bayer, Corteva) and new pharma partnerships underway.
Financial highlights
Q3 2025 operating expenses net: $2.9 million, down from $6.6 million in Q3 2024.
Revenues for nine months ended September 30, 2025: $3.5 million, down from $4 million year-over-year, mainly due to lower AgPlenus revenue and the absence of a one-time Bayer payment.
Operating loss for nine months: $8.8 million, improved from $15.3 million year-over-year.
Net income for Q3 2025: $5.2 million, compared to net loss of $8.2 million in Q3 2024, mainly due to gains from discontinued operations.
Cash and short-term deposits at Q3 end: $16 million, reflecting proceeds from asset sales.
Outlook and guidance
Expectation to maintain reduced expense levels going forward.
Anticipate new pharma and ag-chem collaboration agreements in early 2026, with focus on expanding Campus AI partnerships.
Focused on leveraging ChemPass AI for innovation in pharma and agriculture, with Casterra expected to generate future value.
Ongoing efforts to strengthen position in Brazil's castor farming and expand Casterra's commercial opportunities.
Forward-looking statements highlight potential risks from geopolitical instability and reliance on third-party partners.
How will new pharma partnerships validate ChemPass AI?
What is the projected cash usage for 2026?
How does ChemPass AI maintain its competitive edge?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- GOOG
Q4 2025 revenue rose 18% to $113.8B, with net income up 30% and strong AI-driven growth. - QCOM
Record $12.3B revenue, strong QCT/Auto growth, and Alphawave acquisition boost data center expansion. - GBDC
Net income and NAV declined, dividend reduced, and share repurchases increased amid market shifts. - YUM
Double-digit profit growth, digital expansion, and strategic actions defined the year. - 443060
Record 2025 revenue and profit, strong core growth, and robust 2026 outlook with high dividends. - GAIN
Record new investments and NAV growth highlight a strong quarter with robust distributions. - GAINRecord realized gains and income drove higher NAV and strong distributions in FY25.
- GAINNet investment income reached $9.1M, NAV per share was $12.99, and distributions stayed strong.
- EPAC
Directors, auditor, and executive pay were approved with strong shareholder participation. - ARCC
FY 2025 delivered $2.01 core EPS, $1.86/share net income, and a $29.5B portfolio.
Next Evogene earnings date
Q4 202512 Mar, 2026
Evogene
Next Evogene earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Evogene Ltd. is an Israel-based biotechnology company focused on the development of computational biology-based solutions for agriculture, pharmaceuticals, and industrial applications. The company leverages artificial intelligence and big data analytics to discover and develop products in areas such as crop protection, seed traits, microbiome-based solutions, and drug discovery. The company is headquartered in Rehovot, Israel, and its shares are listed on the NASDAQ and TASE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage